Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
10/24/2012 | CN102743533A Traditional Chinese medicinal qi regulating soup used for blood stasis type functional delayed gastric emptying after stomach operation |
10/24/2012 | CN102743522A Traditional Chinese medicine stone-transforming powder |
10/24/2012 | CN102743510A Chinese medicine preparation for treating acute appendicitis |
10/24/2012 | CN102743509A Traditional Chinese medicine formula for treating gastropathy |
10/24/2012 | CN102743507A Medicine for treating icterohepatitis |
10/24/2012 | CN102743501A Traditional Chinese medicinal formula for treating qi deficiency type uterine prolapse |
10/24/2012 | CN102743489A Chinese medicinal prescription for treating blood-deficiency type irregular menstruation |
10/24/2012 | CN102743481A Traditional Chinese medicine granule for treating dyspepsia of dorkings and preparation method thereof |
10/24/2012 | CN102743480A Traditional Chinese medicine preparation for treating hepatitis and preparation method thereof |
10/24/2012 | CN102743479A Traditional Chinese medicine preparation for treating hepatitis and preparing method thereof |
10/24/2012 | CN102743478A Traditional Chinese medicine preparation for treating hepatitis and preparing method thereof |
10/24/2012 | CN102743477A Traditional Chinese medicine preparation for treating hepatitis and preparation method thereof |
10/24/2012 | CN102743476A Traditional Chinese medicinal qi regulating soup used for deficiency cold type functional delayed gastric emptying after stomach operation |
10/24/2012 | CN102743475A Traditional Chinese medicinal qi regulating soup used for qi stagnation type functional delayed gastric emptying after stomach operation |
10/24/2012 | CN102743470A Spleen strengthening and qi tonifying tablets |
10/24/2012 | CN102743467A Formula of traditional Chinese drug for inflammations of stomach, intestine, appendix, liver, and gall bladder |
10/24/2012 | CN102743466A Ipecac refining technology |
10/24/2012 | CN102743462A Traditional Chinese medicine oral liquid for treating gastroenteritis of swine and preparation method thereof |
10/24/2012 | CN102743460A Chinese medicine preparation for treating hepatopathy and preparation method |
10/24/2012 | CN102743459A Traditional Chinese medicine composition for promoting digestive function |
10/24/2012 | CN102743449A Powder medicament for treating thrush |
10/24/2012 | CN102743446A Chinese medicine powder for detoxifying |
10/24/2012 | CN102743442A Traditional Chinese medicine composition for improving gastrointestinal function and preparation method thereof |
10/24/2012 | CN102743439A Method for extracting terpene components from cipadessa cinerascens |
10/24/2012 | CN102743436A Application of effective part of salvianolic acid in preparing preparation for preventing and treating mouth and throat diseases |
10/24/2012 | CN102743435A Use of perila seed extract with functions of protecting liver and lowering transaminase |
10/24/2012 | CN102743425A Health care product for preventing astriction caused by pharyngitis |
10/24/2012 | CN102743424A Flos chrysanthemi indici effective ingredient and application thereof |
10/24/2012 | CN102743423A Traditional Chinese medicine preparation for treating liver diseases and preparation method thereof |
10/24/2012 | CN102743420A Method for improving intestinal colony structure and application |
10/24/2012 | CN102743416A Preparation method of nano-propolis solution |
10/24/2012 | CN102743415A Medicinal composition for treating diseases of oral cavity, throat and tonsil, and administration method thereof |
10/24/2012 | CN102743403A Parasite expelling tablet for domestic animals and preparation method thereof |
10/24/2012 | CN102743385A Modulators of atp-binding cassette-transporters |
10/24/2012 | CN102743377A Method to promote oral health in companion animals |
10/24/2012 | CN102743369A N-acetylcysteine pharmaceutical composition and preparation method thereof |
10/24/2012 | CN102743368A Compounds for the treatment of metabolic disorders |
10/24/2012 | CN102743351A Pantoprazole sodium freeze-dried medicinal composition |
10/24/2012 | CN102743350A Methionine-vitamin B1 composition injection |
10/24/2012 | CN102743330A Pharmaceutical composition |
10/24/2012 | CN102743323A Chewing tablet |
10/24/2012 | CN102742836A Health food for mitigating alcoholic cirrhosis |
10/24/2012 | CN102327444B Method for preparing traditional Chinese medicine lotion for treating diarrhea type bedsore |
10/24/2012 | CN102274381B Chinese medicinal composition for reducing blood fat, protecting livers and relieving alcoholism and preparation method thereof |
10/24/2012 | CN102099033B Pharmaceutical composition for treatment of fibromyalgia |
10/24/2012 | CN102068673B Quality control method of stomach-strengthening and chest-relieving pill as Chinese herbal preparation |
10/24/2012 | CN102058620B Fistula affused liquid medicine for anal fistula |
10/24/2012 | CN102048906B Content measurement method of abrus herb capsules |
10/24/2012 | CN101957346B Novel method for studying medicament metabolism by using model organism zebrafish |
10/24/2012 | CN101766690B Multipurpose utilization method for improving the value of schisandra chinensis medicinal material |
10/24/2012 | CN101721385B Mesalazine oral controlled release medicine composition |
10/24/2012 | CN101585861B N-glycosyl naphthocarbazole compound and synthesis method and application thereof |
10/24/2012 | CN101531578B Method for preparing axial chirality diaromatic compound with optical activity |
10/24/2012 | CN101473958B Liver-nourishing kidney-boosting compound medlar glutinous rice cake or granular formulation for dietary cure |
10/24/2012 | CN101422424B Mycophenolic acid medicine implantation agent and preparation method and use thereof |
10/24/2012 | CN101374844B Pyrrolopyridazinone compound |
10/24/2012 | CN101208344B (R)-N-methylnaltrexone, processes for its synthesis and its pharmaceutical use |
10/24/2012 | CN101088487B polycondensate, preparation method thereof, cosmetic or drug composition, and use thereof |
10/23/2012 | US8293755 Treatment of statin side effects using uridine derivatives |
10/23/2012 | US8293706 Method for inhibiting release of hepatitis B virus from liver cells |
10/23/2012 | CA2518738C Method and composition for preventing or reducing diarrhea |
10/23/2012 | CA2513567C Cop 1 for treatment of inflammatory bowel diseases |
10/23/2012 | CA2441410C Compounds and method of treatment having agonist-like activity selective at alpha 2b or 2b/2c adrenergic receptors |
10/18/2012 | WO2012141256A1 Method for activating good intestinal bacterium, and composition for activating good intestinal bacterium |
10/18/2012 | WO2012140894A1 Pharmaceutical composition |
10/18/2012 | WO2012140852A1 Composition increasing the activity of dehydrogenase, and composition for liver disease |
10/18/2012 | WO2012140636A1 A probiotic formulation |
10/18/2012 | WO2012140133A1 Nutritional compositions including branched chain fatty acids and methods of using same |
10/18/2012 | WO2012140132A1 Nutritional compositions including branched chain fatty acids for improving gut barrier function |
10/18/2012 | WO2012140118A1 Nutritional compositions including branched chain fatty acids for wound healing |
10/18/2012 | WO2012139993A1 1,3 oxazines as bace1 and/or bace2 inhibitors |
10/18/2012 | WO2012139876A1 Enteric formulations of metabotropic glutamate receptor modulators |
10/18/2012 | WO2012115480A3 Diaminopyrimidine derivatives and processes for the preparation thereof |
10/18/2012 | WO2012115478A3 Diaminopyrimidine derivatives and processes for the preparation thereof |
10/18/2012 | WO2012113850A3 (PYRIDIN-4-YL)BENZYLAMIDES AS ALLOSTERIC MODULATORS OF ALPHA 7 nAChR |
10/18/2012 | WO2012100043A3 Controlled release oral pharmaceutical dosage forms comprising mgbg |
10/18/2012 | US20120264966 Sulfur-containing phospholipid derivatives |
10/18/2012 | US20120264824 Compositions and methods for treating non-alcoholic steatohepatitis |
10/18/2012 | US20120264816 Sulfated Oxysterol and Oxysterol Sulfation by Hydroxysterol Sulfotransferase Promote Lipid Homeostasis and Liver Proliferation |
10/18/2012 | US20120264805 Medicament for the treatment and prevention of liver failure |
10/18/2012 | US20120264799 Indane-amine derivatives, their preparation and use as medicaments |
10/18/2012 | US20120264798 Prodrugs of inhibitors of plasma kallikrein |
10/18/2012 | US20120264797 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
10/18/2012 | US20120264779 Quinolinone-carboxamide compounds as 5-ht4 receptor agonists |
10/18/2012 | US20120264774 Forms of rifaximin and uses thereof |
10/18/2012 | US20120264762 Heterocyclic Compounds as CCR2 Antagonists |
10/18/2012 | US20120264756 Phosphatidylcholine Transfer Protein Inhibitors |
10/18/2012 | US20120264755 Pyridinyl derivatives as inhibitors of enzyme nicotinamide phosphoribosyltransferase |
10/18/2012 | US20120264749 Morpholine-spirocyclic piperidine amides as modulators of ion channels |
10/18/2012 | US20120264743 Crystalline forms of (r)-8-chloro-1-methyl-2,3,4,5-thtrahydro-1h-3-benzazepine hydrochloride |
10/18/2012 | US20120264732 Phenyl bicyclic methyl azetidine derivatives as sphingosine-1 phosphate receptors modulators |
10/18/2012 | US20120264730 Substituted bicyclic methyl azetidines as sphingosine-1 phosphate receptors modulators |
10/18/2012 | US20120264721 Analogues of cilostazol |
10/18/2012 | US20120264717 Compounds, Compositions and Methods Comprising Oxadiazole Derivatives |
10/18/2012 | US20120264716 Phenyl bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators |
10/18/2012 | US20120264715 Substituted bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators |
10/18/2012 | US20120264714 Boron-containing small molecules as anti-inflammatory agents |
10/18/2012 | US20120264711 Antiviral compounds |
10/18/2012 | US20120264698 Method of using dopamine reuptake inhibitors and their analogs for treating autoimmune conditions and delaying or preventing autoimmune related pathologic progressions |
10/18/2012 | US20120263804 Essential element extractor |